Daclizumab Subcutaneous and HumaLOG KwikPen
Determining the interaction of Daclizumab Subcutaneous and HumaLOG KwikPen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: insulin lispro
Brand name: HumaLOG KwikPen, Admelog, Humalog, HumaLOG Pen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Humalog Mix
- Daclizumab Subcutaneous-Humalog Mix 50/50
- Daclizumab Subcutaneous-Humalog Mix 50/50 (Insulin Lispro Protamine and Insulin Lispro (Pens))
- Daclizumab Subcutaneous-HumaLog Mix 50/50 (Insulin Lispro Protamine and Insulin Lispro (Vials))
- Daclizumab Subcutaneous-Humalog Mix 50/50 KwikPen
- Daclizumab Subcutaneous-Humalog Mix 75/25
- HumaLOG KwikPen-Dacogen
- HumaLOG KwikPen-Dacomitinib
- HumaLOG KwikPen-Dactinomycin
- HumaLOG KwikPen-Dactinomycin Injection
- HumaLOG KwikPen-Dactinomycin Intravenous
- HumaLOG KwikPen-Daklinza